## Abstract Pathological gambling (PG) has been reported as a complication of the treatment of Parkinson's disease (PD). We examined all published cases of PG for prevalence and risk factors of this complication, the relationship of PG and use of dopamine agonists (DA), and the relationship of PG t
Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?
β Scribed by Petra Schwingenschuh; Petra Katschnig; Ronald Saurugg; Erwin Ott; Kailash P. Bhatia
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 668 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of atβrisk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factorsβyoung age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorderβengagement in a creative or artistic profession may be an additional risk factor for developing DDS. Β© 2010 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract To determine whether the risk factors for dementia in idiopathic Parkinson's disease (IPD) are similar to the risk factors for Alzheimer's disease, we conducted a caseβcontrol study of potential risk factors. A structured interview as was administered to surrogates of 17 demented subjec
## Abstract Parkinson's disease (PD) is a common neurodegenerative disorder caused by loss of dopaminergic neurons in the brainstem. Recent studies suggest that several genes may have a role in determining individual susceptibility to this disease, and the degradative enzyme monoamine oxidase (MAO)